“Outcome of 12-weeks Triple Therapy (TT), including Sofosbuvir (SOF), Ribavirin and Pegylated interferon-Alfa in all non-cirrhotic patients with chronic Hepatitis-C Genotype-3 infection” (2024) Medical Forum Monthly, 28(7). Available at: https://medicalforummonthly.com/index.php/mfm/article/view/4148 (Accessed: 16 November 2025).